个人简介
Piermarco Piatti是IRCCS圣拉斐尔科学研究医院普通内科下属的心脏代谢和临床试验科室负责人，在Emanuele Bosi教授的指导下开展工作，侧重于糖尿病和代谢性内分泌疾病等领域。
1981年，Piatti医生从米兰大学毕业并获得医学学位。1985年又在该校获得糖尿病和代谢性疾病专业学位，随后获得生物化学和临床化学专业学位。2005年，在那不勒斯腓特烈二世大学获得心血管系统疾病康复硕士学位。在职业生涯中，Piatti医生积累了丰富的海外留学经历（英国纽卡斯尔大学和法国里昂克劳德·伯纳德大学）。
Piermarco Piatti医生的临床和门诊工作主要与糖尿病和血脂异常有关，他一直与所在机构的心脏内科、心脏外科、胸外科、血管外科、传染病科和精神科开展日常合作。
Piatti医生是意大利糖尿病学会伦巴第分会主席，也是意大利糖尿病学会动脉硬化症和心血管疾病组的国家协调员。
他在糖尿病和心血管疾病预防和治疗方面开展实验性临床试验，是约30项与糖尿病、血脂异常、心血管疾病和肾衰竭预防和治疗相关的申办临床试验的主要研究者。
他多次以作者或共同作者的身份在行业学术期刊上发表论文，也参与了书籍章节的编写，共计200篇文章。H指数为36。多次参加意大利国内外的行业会议。
教育背景
米兰大学
1981年，医学博士学位
米兰大学
1985年，糖尿病和代谢病专业学位
米兰大学
1990年，生物化学和临床化学专业学位
那不勒斯腓特烈二世大学
2005年，心血管康复硕士学位
出版物
最新出版物
Decreased Diabetes risk over 9 year after 18 months oral L-arginine treatment in middle-aged subjects with impaired glucose tolerance and metabolic syndrome (extension evaluation of L-arginine study)
Eur J Nutr, 2017, DOI: 10.1007/s00394-017-1548-2
扩展阅读
Lixilan-O trial investigators. Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial.
Diabetes Care. ;39:2026-2035; 2016
扩展阅读
Pharmacogenetic influence of eNOS gene variant on endothelial and glucose metabolism responses to L-arginine supplementation: Post hoc analysis ofthe L-arginine trial
Metabolism, 64:1582-91; 2015.
扩展阅读
A novel truncated form of eNOS associates with altered vascular function.
Cardiovasc Res. 101:492-502, 2014.
扩展阅读
Smoking is associated with impaired glucose regulation and a decrease in insulin sensitivity and the disposition index in first-degree relatives of type 2 diabetes subjects independently of the presence of metabolic syndrome
Acta Diabetol. 51:793-9, 2014.
扩展阅读
L-Arginine enriched biscuits improve endothelial function and glucose metabolism: A pilot study in healthy subjects and a cross-over study in subjects with impaired glucose tolerance and metabolic syndrome.
Metabolism. 62:255-64, 2013.
扩展阅读
Effect of normalization of fasting glucose by intensified insulin therapy and influence of eNOS polymorphisms on the incidence of restenosis after peripheral angioplasty in patients with type 2 diabetes: a randomized, open-label clinical trial.
Acta Diabetol. 50:373-82, 2013
扩展阅读
Effects of chronic elevation of atrial natriuretic peptide and free fatty acid levels in the induction of type 2 diabetes mellitus and insulin resistance in patients with mitral valve disease.
Nutr Metab Cardiovasc Dis. 2012 22:58-65, 2012.
扩展阅读
Effect of a long-term oral l-arginine supplementation on glucose metabolism: a randomized, double-blind, placebo-controlled trial.
Diabetes Obes Metab. 14:893-900, 2012.
扩展阅读
Long-term oral L-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients.
Diabetes Care 24: 875-880, 2001
扩展阅读
Acute Intravenous L-Arginine Infusion Decreases Endothelin-1 Levels and Improves Endothelial Function in Patients with Angina Pectoris and Normal Coronary Arteriograms: Correlation with ADMA Levels
Circulation 107:429-36, 2003
扩展阅读
Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome
Diabetes 52:1270-5, 2003.
扩展阅读
Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting
Circulation 108:2074-2081, 2003.
扩展阅读
Hypocaloric high protein diet improves glucose oxidation and spares lean body mass. Comparison with hypocaloric high complex carbohydrate diet
Metabolism 43:1481-1487, 1994
扩展阅读
Forearm insulin- and non-insulin-mediated glucose uptake and muscle metabolism in man: role of free fatty acids and blood glucose levels.
Metabolism 40: 926-933,1991
扩展阅读